Construction at the Norton site is currently underway, with the new offerings anticipated to be operational by late 2027.

With demand for its RNA interference meds booming, Alnylam Pharmaceuticals has commenced work to soup up its flagship ...

Dr Lal PathLabs , one of India’s leading diagnostic chains, has launched Sovaaka, a new preventive healthcare and wellness ...

A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer’s disease. Researchers discovered that LPCs—compounds that transport a variety of healthy ...

Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two ...